Oxford-AstraZeneca COVID-19 vaccine (AZD1222) is ideal for resource-constrained low- and middle-income countries

Detalles Bibliográficos
Autores principales: Sharun, Khan, Singh, Rajendra, Dhama, Kuldeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010342/
https://www.ncbi.nlm.nih.gov/pubmed/33815783
http://dx.doi.org/10.1016/j.amsu.2021.102264
_version_ 1783673043544965120
author Sharun, Khan
Singh, Rajendra
Dhama, Kuldeep
author_facet Sharun, Khan
Singh, Rajendra
Dhama, Kuldeep
author_sort Sharun, Khan
collection PubMed
description
format Online
Article
Text
id pubmed-8010342
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-80103422021-03-31 Oxford-AstraZeneca COVID-19 vaccine (AZD1222) is ideal for resource-constrained low- and middle-income countries Sharun, Khan Singh, Rajendra Dhama, Kuldeep Ann Med Surg (Lond) Correspondence Elsevier 2021-03-31 /pmc/articles/PMC8010342/ /pubmed/33815783 http://dx.doi.org/10.1016/j.amsu.2021.102264 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Sharun, Khan
Singh, Rajendra
Dhama, Kuldeep
Oxford-AstraZeneca COVID-19 vaccine (AZD1222) is ideal for resource-constrained low- and middle-income countries
title Oxford-AstraZeneca COVID-19 vaccine (AZD1222) is ideal for resource-constrained low- and middle-income countries
title_full Oxford-AstraZeneca COVID-19 vaccine (AZD1222) is ideal for resource-constrained low- and middle-income countries
title_fullStr Oxford-AstraZeneca COVID-19 vaccine (AZD1222) is ideal for resource-constrained low- and middle-income countries
title_full_unstemmed Oxford-AstraZeneca COVID-19 vaccine (AZD1222) is ideal for resource-constrained low- and middle-income countries
title_short Oxford-AstraZeneca COVID-19 vaccine (AZD1222) is ideal for resource-constrained low- and middle-income countries
title_sort oxford-astrazeneca covid-19 vaccine (azd1222) is ideal for resource-constrained low- and middle-income countries
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010342/
https://www.ncbi.nlm.nih.gov/pubmed/33815783
http://dx.doi.org/10.1016/j.amsu.2021.102264
work_keys_str_mv AT sharunkhan oxfordastrazenecacovid19vaccineazd1222isidealforresourceconstrainedlowandmiddleincomecountries
AT singhrajendra oxfordastrazenecacovid19vaccineazd1222isidealforresourceconstrainedlowandmiddleincomecountries
AT dhamakuldeep oxfordastrazenecacovid19vaccineazd1222isidealforresourceconstrainedlowandmiddleincomecountries

Ejemplares similares